Cargando…
Toward G protein-coupled receptor structure-based drug design using X-ray lasers
Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-di...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830214/ https://www.ncbi.nlm.nih.gov/pubmed/31709066 http://dx.doi.org/10.1107/S2052252519013137 |
_version_ | 1783465736217296896 |
---|---|
author | Ishchenko, Andrii Stauch, Benjamin Han, Gye Won Batyuk, Alexander Shiriaeva, Anna Li, Chufeng Zatsepin, Nadia Weierstall, Uwe Liu, Wei Nango, Eriko Nakane, Takanori Tanaka, Rie Tono, Kensuke Joti, Yasumasa Iwata, So Moraes, Isabel Gati, Cornelius Cherezov, Vadim |
author_facet | Ishchenko, Andrii Stauch, Benjamin Han, Gye Won Batyuk, Alexander Shiriaeva, Anna Li, Chufeng Zatsepin, Nadia Weierstall, Uwe Liu, Wei Nango, Eriko Nakane, Takanori Tanaka, Rie Tono, Kensuke Joti, Yasumasa Iwata, So Moraes, Isabel Gati, Cornelius Cherezov, Vadim |
author_sort | Ishchenko, Andrii |
collection | PubMed |
description | Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-discovery projects, its application to G protein-coupled receptors (GPCRs) has been limited owing to extreme difficulties with their crystallization. Here, a method is presented for the rapid determination of multiple co-crystal structures for a target GPCR in complex with various ligands, taking advantage of the serial femtosecond crystallography approach, which obviates the need for large crystals and requires only submilligram quantities of purified protein. The method was applied to the human β(2)-adrenergic receptor, resulting in eight room-temperature co-crystal structures with six different ligands, including previously unreported structures with carvedilol and propranolol. The generality of the proposed method was tested with three other receptors. This approach has the potential to enable SBDD for GPCRs and other difficult-to-crystallize membrane proteins. |
format | Online Article Text |
id | pubmed-6830214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-68302142019-11-08 Toward G protein-coupled receptor structure-based drug design using X-ray lasers Ishchenko, Andrii Stauch, Benjamin Han, Gye Won Batyuk, Alexander Shiriaeva, Anna Li, Chufeng Zatsepin, Nadia Weierstall, Uwe Liu, Wei Nango, Eriko Nakane, Takanori Tanaka, Rie Tono, Kensuke Joti, Yasumasa Iwata, So Moraes, Isabel Gati, Cornelius Cherezov, Vadim IUCrJ Research Papers Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-discovery projects, its application to G protein-coupled receptors (GPCRs) has been limited owing to extreme difficulties with their crystallization. Here, a method is presented for the rapid determination of multiple co-crystal structures for a target GPCR in complex with various ligands, taking advantage of the serial femtosecond crystallography approach, which obviates the need for large crystals and requires only submilligram quantities of purified protein. The method was applied to the human β(2)-adrenergic receptor, resulting in eight room-temperature co-crystal structures with six different ligands, including previously unreported structures with carvedilol and propranolol. The generality of the proposed method was tested with three other receptors. This approach has the potential to enable SBDD for GPCRs and other difficult-to-crystallize membrane proteins. International Union of Crystallography 2019-10-24 /pmc/articles/PMC6830214/ /pubmed/31709066 http://dx.doi.org/10.1107/S2052252519013137 Text en © Andrii Ishchenko et al. 2019 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Research Papers Ishchenko, Andrii Stauch, Benjamin Han, Gye Won Batyuk, Alexander Shiriaeva, Anna Li, Chufeng Zatsepin, Nadia Weierstall, Uwe Liu, Wei Nango, Eriko Nakane, Takanori Tanaka, Rie Tono, Kensuke Joti, Yasumasa Iwata, So Moraes, Isabel Gati, Cornelius Cherezov, Vadim Toward G protein-coupled receptor structure-based drug design using X-ray lasers |
title | Toward G protein-coupled receptor structure-based drug design using X-ray lasers |
title_full | Toward G protein-coupled receptor structure-based drug design using X-ray lasers |
title_fullStr | Toward G protein-coupled receptor structure-based drug design using X-ray lasers |
title_full_unstemmed | Toward G protein-coupled receptor structure-based drug design using X-ray lasers |
title_short | Toward G protein-coupled receptor structure-based drug design using X-ray lasers |
title_sort | toward g protein-coupled receptor structure-based drug design using x-ray lasers |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830214/ https://www.ncbi.nlm.nih.gov/pubmed/31709066 http://dx.doi.org/10.1107/S2052252519013137 |
work_keys_str_mv | AT ishchenkoandrii towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT stauchbenjamin towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT hangyewon towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT batyukalexander towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT shiriaevaanna towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT lichufeng towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT zatsepinnadia towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT weierstalluwe towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT liuwei towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT nangoeriko towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT nakanetakanori towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT tanakarie towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT tonokensuke towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT jotiyasumasa towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT iwataso towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT moraesisabel towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT gaticornelius towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers AT cherezovvadim towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers |